Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Willson L, Monyak DJ, Sullivan P, Stanberry L, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovascular Revascularization Medicine 2020, 22: 29-33. PMID: 32571761, DOI: 10.1016/j.carrev.2020.06.019.Peer-Reviewed Original ResearchMeSH KeywordsAtherectomyBrachytherapyCoronary RestenosisDrug-Eluting StentsHumansLasersStentsTreatment OutcomeConceptsTarget lesion failureTarget lesion revascularizationLong-term outcomesVascular brachytherapyDrug-eluting stentsMyocardial infarctionLaser atherectomyDES-ISRCardiac deathStent restenosisIncidence of TLFComparable long-term outcomesRecurrent DES-ISRExcimer laser atherectomyLesion myocardial infarctionTarget-lesion myocardial infarctionRecurrent drugsLesion failureLesion revascularizationISR lesionsStent underexpansionSingle institutionTarget lesionsAtherectomyStudy period